Abstract. Glucose metabolism was studied by a somatostatin-insulin-glucose infusion test (SIGIT) 
Posthypoglycaemic hyperglycaemia as described by Somogyi ( 1959) has been recognized in clinical practice for many years, but most data supporting the existence of the phenomenon have as yet been based on uncontrolled reports. Interestingly, in two recently performed controlled studies, hypo¬ glycaemia during the day was followed by insulin resistance as expressed by rising blood glucose concentrations (Bolli et al. 1984; Kollind et al., unpublished results). In contrast, other investiga¬ tors, mainly concerned with the morning blood glucose concentration, have questioned whether rebound hyperglycaemia generally occurs after nocturnal hypoglycaemia. Thus, Gale et al. (1980) were able to demonstrate such a glycaemic re¬ bound in only a minority of their patients. More¬ over, fasting morning blood glucose concentra¬ tions have been reported as lower in diabetics affected by nocturnal hypoglycaemia (Vonesch et al. 1984; Pramming et al. 1985) . Taken together, these conflicting results might indicate that dif¬ ferent metabolic consequences follow hypoglycae¬ mia provoked at night as compared with diurnal hypoglycaemia. By using the somatostatin-insulinglucose-infusion test, whereby we have previously documented the existence of insulin resistance after diurnal hypoglycaemia (Kollind et al., un¬ published results), we sought in the present study to elucidate whether nocturnal hypoglycaemia is also followed by insulin resistance.
Material and Methods
Seven male patients with diabetes without residual ß-cell function (plasma C-peptide < 0.1 nmol/1 after a mixed meal) were studied on two occasions. Clinical information pertinent to these patients is included in Table 1 Insulin infusion rate (U/h) during the day and night before start of SIGIT in the study with (-) and without ("") hypoglycaemia, and the plasma free insulin levels during the night in the study with (·-·) and without hypoglycaemia (O-O).
was determined by a polyethylene-glycol precipitation method (Nakagawa et al. 1973 ) and C-peptide by a radioimmunoassay technique (Heding 1975 (Fig. 1) . During the night without hypoglycaemia, the typical early morning rise of cortisol was observed, whereas plasma glucagon, GH, and epinephrine remained virtually at basal levels (Fig. 1) . In both studies, the blood glucose level was about 6 mmol/ 1 and the levels of counterregulatory hormones had returned to basal when SIGIT was started. The insulin infusion rate between 5.30 and 7.00 h was not different between the control and the hypoglycaemic study, which was also reflected by the similar plasma free insulin levels at the start of the SIGIT at 7.00 h (Fig. 2) .
Plasma glucagon was suppressed by 30% during the SIGIT and plasma GH was low or immeasur¬ able, whereas plasma cortisol was gradually de¬ creasing owing to its normal diurnal rhythmicity (Fig. 3) . No differences were disclosed for plasma free insulin, glucagon, GH or cortisol between the two SIGIT periods, whereas glycaemia was much more pronounced when the SIGIT was preceded by hypoglycaemia (Figs. 3 and 4) . This was also reflected by an increased urinary excretion of glucose (189 ± 51 vs 45 ± 40 mmol, < 0.005). 
Discussion
In the present study, nocturnal hypoglycaemia was found to induce a state of insulin resistance up to 12 h after nadir hypoglycaemia. This could be of major importance for explaining the re¬ bound hyperglycaemia phenomenon. When ori¬ ginally described, this phenomenon was referred to as the occurrence of excessive urinary glucose output after hypoglycaemia in juvenile onset dia¬ betics (Somogyi 1959 (1980) questioned the importance of counterregulatory hormones suggesting that rebound hyperglycae¬ mia is the consequence of early morning insulinopenia only. Their conclusion was supported by a study on the subcutaneous absorption of insulin, in which rebound hyperglycaemia was observed only in patients with Type I diabetes mellitus with low insulin absorption rates following the hypo¬ glycaemic attack (Lauritzen et al. 1979 Bolli et al. (1984) (Rizza et al. 1979 (Kollind et al. 1987 ). Cortisol probably acts by enhancing the action of other counterregulatory hormones (Shamoon et al. 1981) . We therefore interpret the present find¬ ings as suggesting that posthypoglycaemic insulin resistance, as seen in the present study, might be dependent on GH.
In conclusion, the present study demonstrates that insulin resistance occurs after nocturnal hypoglycaemia in well insulinized IDDM patients, which is in accordance with previous observations that insulin resistance follows upon hypoglycae¬ mia induced by insulin during the day. Insulin resistance following hypoglycaemia might be of importance in explaining glycaemic instability in insulin-treated diabetic patients.
